Higher incidence of neurotoxicity and skin hyperpigmentation in renal transplant patients treated with polymyxin B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Higher incidence of neurotoxicity and skin hyperpigmentation in renal transplant patients treated with polymyxin B

Published:2022-05-29 Issue:11 Volume:88 Page:4742-4750
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Zhou Yangang¹²,Li Ying¹²,Xie Xubiao³,Song Lei³,Lan Gongbin³,Sun Bao¹²,Tang Tiantian¹²,Yan Han¹²,Zhang Bikui¹²,Xu Ping¹²^ORCID

Affiliation:

1. Department of Pharmacy, The Second Xiangya Hospital Central South University Changsha China

2. Institute of Clinical Pharmacy Central South University Changsha China

3. Department of Kidney Transplantation, The Second Xiangya Hospital Central South University Changsha China

Funder

Natural Science Foundation of Hunan Province

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15384

Reference39 articles.

1. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

2. Adverse Reactions Associated with Systemic Polymyxin Therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins;BMC Infectious Diseases;2024-08-26

2. Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease;Clinical Kidney Journal;2024-06-14

3. A pharmacovigilance study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database;Expert Opinion on Drug Safety;2024-05

4. Polymixin-B;Reactions Weekly;2023-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3